OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The potential of serum neurofilament as biomarker for multiple sclerosis
Stefan Bittner, Jiwon Oh, Eva Havrdová, et al.
Brain (2021) Vol. 144, Iss. 10, pp. 2954-2963
Open Access | Times Cited: 152
Stefan Bittner, Jiwon Oh, Eva Havrdová, et al.
Brain (2021) Vol. 144, Iss. 10, pp. 2954-2963
Open Access | Times Cited: 152
Showing 1-25 of 152 citing articles:
Multiple sclerosis progression: time for a new mechanism-driven framework
Tanja Kuhlmann, Marcello Moccia, Timothy Coetzee, et al.
The Lancet Neurology (2022) Vol. 22, Iss. 1, pp. 78-88
Open Access | Times Cited: 321
Tanja Kuhlmann, Marcello Moccia, Timothy Coetzee, et al.
The Lancet Neurology (2022) Vol. 22, Iss. 1, pp. 78-88
Open Access | Times Cited: 321
Multiple sclerosis
Dejan Jakimovski, Stefan Bittner, Robert Zivadinov, et al.
The Lancet (2023) Vol. 403, Iss. 10422, pp. 183-202
Closed Access | Times Cited: 173
Dejan Jakimovski, Stefan Bittner, Robert Zivadinov, et al.
The Lancet (2023) Vol. 403, Iss. 10422, pp. 183-202
Closed Access | Times Cited: 173
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 144
Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 144
Neurofilaments as biomarkers in neurological disorders — towards clinical application
Michael Khalil, Charlotte E. Teunissen, Sylvain Lehmann, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 5, pp. 269-287
Closed Access | Times Cited: 102
Michael Khalil, Charlotte E. Teunissen, Sylvain Lehmann, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 5, pp. 269-287
Closed Access | Times Cited: 102
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Burak Arslan, Henrik Zetterberg
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 7, pp. 1140-1149
Open Access | Times Cited: 38
Burak Arslan, Henrik Zetterberg
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 7, pp. 1140-1149
Open Access | Times Cited: 38
Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy
Panoraia Baka, Livia Steenken, Fabiola Escolano‐Lozano, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 4
Open Access | Times Cited: 13
Panoraia Baka, Livia Steenken, Fabiola Escolano‐Lozano, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 4
Open Access | Times Cited: 13
Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis
Kian Jalaleddini, Dejan Jakimovski, Anisha Keshavan, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 3, pp. 729-743
Open Access | Times Cited: 8
Kian Jalaleddini, Dejan Jakimovski, Anisha Keshavan, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 3, pp. 729-743
Open Access | Times Cited: 8
Biomarkers in neurodegenerative diseases: a broad overview
Selvam Sathish, Velpandi Ayyavoo
Exploration of Neuroprotective Therapy (2024), pp. 119-147
Open Access | Times Cited: 8
Selvam Sathish, Velpandi Ayyavoo
Exploration of Neuroprotective Therapy (2024), pp. 119-147
Open Access | Times Cited: 8
Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis
Kimberly Koerbel, Michelle Maiworm, Martin Schaller, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 87, pp. 105644-105644
Open Access | Times Cited: 8
Kimberly Koerbel, Michelle Maiworm, Martin Schaller, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 87, pp. 105644-105644
Open Access | Times Cited: 8
BDNF levels in serum and CSF are associated with clinicoradiological characteristics of aggressive disease in MS patients
Michelle Maiworm, Kimberly Koerbel, Victoria Anschütz, et al.
Journal of Neurology (2025) Vol. 272, Iss. 2
Open Access | Times Cited: 1
Michelle Maiworm, Kimberly Koerbel, Victoria Anschütz, et al.
Journal of Neurology (2025) Vol. 272, Iss. 2
Open Access | Times Cited: 1
The 2022 Lady Estelle Wolfson lectureship on neurofilaments
Axel Petzold
Journal of Neurochemistry (2022) Vol. 163, Iss. 3, pp. 179-219
Open Access | Times Cited: 30
Axel Petzold
Journal of Neurochemistry (2022) Vol. 163, Iss. 3, pp. 179-219
Open Access | Times Cited: 30
Improved prediction of early cognitive impairment in multiple sclerosis combining blood and imaging biomarkers
Tobias Brummer, Muthuraman Muthuraman, Falk Steffen, et al.
Brain Communications (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 29
Tobias Brummer, Muthuraman Muthuraman, Falk Steffen, et al.
Brain Communications (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 29
Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials
Tjalf Ziemssen, Douglas L. Arnold, Enríque Alvarez, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Tjalf Ziemssen, Douglas L. Arnold, Enríque Alvarez, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Magnetic transferrin nanoparticles (MTNs) assay as a novel isolation approach for exosomal biomarkers in neurological diseases
Yoon Ok Jang, Hee‐Sung Ahn, Thuy Nguyen Thi Dao, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 21
Yoon Ok Jang, Hee‐Sung Ahn, Thuy Nguyen Thi Dao, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 21
Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting
Priscilla Youssef, Laura P. Hughes, Woojin S. Kim, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Priscilla Youssef, Laura P. Hughes, Woojin S. Kim, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Neurofilament Biophysics: From Structure to Biomechanics
Erika A. Ding, Sanjay Kumar
Molecular Biology of the Cell (2024) Vol. 35, Iss. 5
Open Access | Times Cited: 6
Erika A. Ding, Sanjay Kumar
Molecular Biology of the Cell (2024) Vol. 35, Iss. 5
Open Access | Times Cited: 6
Neurofilaments contribution in clinic: state of the art
Constance Delaby, Olivier Bousiges, Damien Bouvier, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 27
Constance Delaby, Olivier Bousiges, Damien Bouvier, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 27
Glial Fibrillary Acidic Protein in Blood as a Disease Biomarker of Neuromyelitis Optica Spectrum Disorders
Hyunjin Kim, Eun‐Jae Lee, Young‐Min Lim, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 25
Hyunjin Kim, Eun‐Jae Lee, Young‐Min Lim, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 25
Multiple Sclerosis and Microbiome
Jana Lízrová Preiningerová, Zuzana Jirásková Zákostelská, Adhish Srinivasan, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 433-433
Open Access | Times Cited: 25
Jana Lízrová Preiningerová, Zuzana Jirásková Zákostelská, Adhish Srinivasan, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 433-433
Open Access | Times Cited: 25
Neuromyelitis Optica Spectrum Disorders
Fiona Costello
CONTINUUM Lifelong Learning in Neurology (2022) Vol. 28, Iss. 4, pp. 1131-1170
Closed Access | Times Cited: 24
Fiona Costello
CONTINUUM Lifelong Learning in Neurology (2022) Vol. 28, Iss. 4, pp. 1131-1170
Closed Access | Times Cited: 24
Effect of Estimated Blood Volume and Body Mass Index on GFAP and NfL Levels in the Serum and CSF of Patients With Multiple Sclerosis
Yavor Yalachkov, Jan Hendrik Schäfer, Jasmin Jakob, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Yavor Yalachkov, Jan Hendrik Schäfer, Jasmin Jakob, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Associations ofsNfL with clinico‐radiological measures in a largeMS population
Elias S. Sotirchos, Kathryn C. Fitzgerald, Carol M. Singh, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 10, Iss. 1, pp. 84-97
Open Access | Times Cited: 24
Elias S. Sotirchos, Kathryn C. Fitzgerald, Carol M. Singh, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 10, Iss. 1, pp. 84-97
Open Access | Times Cited: 24
Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
Synne Brune, Einar A. Høgestøl, Sigrid A. de Rodez Benavent, et al.
Multiple Sclerosis Journal (2022) Vol. 28, Iss. 12, pp. 1859-1870
Open Access | Times Cited: 23
Synne Brune, Einar A. Høgestøl, Sigrid A. de Rodez Benavent, et al.
Multiple Sclerosis Journal (2022) Vol. 28, Iss. 12, pp. 1859-1870
Open Access | Times Cited: 23
Molecular biomarkers and cognitive impairment in multiple sclerosis: State of the field, limitations, and future direction – A systematic review and meta-analysis
Tom-D. Rademacher, Sven G. Meuth, Heinz Wiendl, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105035-105035
Closed Access | Times Cited: 15
Tom-D. Rademacher, Sven G. Meuth, Heinz Wiendl, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105035-105035
Closed Access | Times Cited: 15
Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients.
Domizia Vecchio, Chiara Puricelli, Simona Malucchi, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 82, pp. 105412-105412
Open Access | Times Cited: 14
Domizia Vecchio, Chiara Puricelli, Simona Malucchi, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 82, pp. 105412-105412
Open Access | Times Cited: 14
